Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Schlesinger N, Schlesinger M, Seshan SV. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J Rheumatol. 2005;32(6):1053-7.

Patterson CC, Ross P, Pope-Harman AL, Knight DA, Magro CM. Alpha-1 anti-trypsin deficiency and Henoch-Schönlein purpura associated with anti-neutrophil cytoplasmic and anti-endothelial cell antibodies of immunoglobulin-A isotype. J Cutan Pathol. 2005;32(4):300-6.

Jang B-, Jung T-, Paik J-, Kwon Y-, Shin S-, Kim S-, et al. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-kappaB. Biochem Biophys Res Commun. 2005;328(1):70-7.

Rubio CA, Nesi G, Zampi GC, de Ruiz PA, Jessurun J, Jónasson J, et al. Gastric ciliated metaplasia. A study of 3406 gastrectomy specimens from dwellers of the Atlantic and the Pacific basins. J Clin Pathol. 2005;58(6):605-10.

Wooten MW, Geetha T, M Seibenhener L, J Babu R, Diaz-Meco MT, Moscat J. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J Biol Chem. 2005;280(42):35625-9.

Magro CM, Frambach GE, A Crowson N. Chondrodermatitis nodularis helicis as a marker of internal disease [corrected] associated with microvascular injury. J Cutan Pathol. 2005;32(5):329-33.

Chiarle R, Simmons WJ, Cai H, Dhall G, Zamò A, Raz R, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005;11(6):623-9.

Chang H, Gwack Y, Kingston D, Souvlis J, Liang X, Means RE, et al. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. J Virol. 2005;79(8):4651-63.

Schulz L, Tyler J. Heterochromatin focuses on senescence. Mol Cell. 2005;17(2):168-70.

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343-51.